Interleukin-1β (IL-1) Does Not Reduce the Diabetes Incidence in Diabetes-Prone Bb Rats

References

• Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619–33
   PubMed Web of Science ®Google Scholar
• Voorbij HAM, Jeucken PHM, Kabel PJ, de Haan M, Drex-Hage HA. Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats. Diabetes 1989; 38: 1623–9
   PubMed Web of Science ®Google Scholar
• Signora A, Pozzilli P, Gale EAM, Andreani D, Beverley PCL. The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia 1989; 32: 282–9
   Google Scholar
• Mandrup-Poulsen T, Helqvist S, Mølvig J, Wogensen LD, Nerup J. Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus. Autoimmunity 1989; 4: 191–218
   PubMedGoogle Scholar
• Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH. Affinity purified human Interleukin 1 is cytotoxic to isolated islets of Langerhans. Diabetologia 1986; 29: 63–7
   PubMed Web of Science ®Google Scholar
• Sandler S, Andersson A, Hellerström C. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 1987; 121: 1424–31
   PubMed Web of Science ®Google Scholar
• Spinas GA, Palmer JP, Mandrup-Poulsen T, Andersen H, Nielsen JH, Nerup J. The bimodal effect of interleukin 1 on rat pancreatic beta-cells – stimulation followed by inhibition – depends upon dose, duration of exposure, and ambient glucose concentration. Acta Endocinol (Copenh) 1988; 119: 307–11
   PubMedGoogle Scholar
• Mandrup-Poulsen T, Egeberg J, Nerup J, Bendtzen K, Nielsen JH, Dinarello CA. Ultra-structural studies of time-course and cellular specificity of Interleukin-1 mediated islet cytotoxicity. Acta Path Microbiol Immunol Scand (C) 1987; 95: 55–63
   Google Scholar
• Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic β-cell cytotoxicity. J Immunol 1987; 139: 4077–82
   PubMed Web of Science ®Google Scholar
• Pukel C, Baquerizo H, Rabinovitch A. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of Interferony, Tumor Necrosis Factor, Lymphotoxin, and Interleukin 1. Diabetes 1988; 37: 133–6
   PubMed Web of Science ®Google Scholar
• Wogensen L, Reimers J, Nerup J, Kolb-Bachofen V, Kröncke K-D, Almdal T, Mandrup-Poulsen T. Repetitive in vivo treatment with human recombinant interleukin 1β modify Beta-cell function in normal rats. Diabetologia 1992; 35: 331–9
   Google Scholar
• Jiang Z, Woda BA. Cytokine gene expression in the islets of the diabetic Biobreeding/Worcester rat. J Immunol 1991; 146: 2990–4
   PubMed Web of Science ®Google Scholar
• Held W, MacDonald HR, Weissman IL, Hess MW, Mueller C. Genes encoding tumor necrosis factor a and granzyme A are expressed during development of autoimmune diabetes. Proc Natl Acad Sci USA 1990; 87: 2239–43
   PubMed Web of Science ®Google Scholar
• Wilson CA, Jacobs C, Baker P, Baskin DG, Dower S, Lernmark A, Toivola B, Vertrees S, Wilson D. IL-1β modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. J. Immunol 1990; 144: 3784–8
   PubMed Web of Science ®Google Scholar
• Vertrees S, Wilson CA, Ubungen R, Wilson D, Baskin DG, Toivola B, Jacobs C, Boiani N, Baker P., Lernmark Å. Interleukin-1β regulation of islet and thyroid autoimmunity in the BB rat. J Autoimmun 1991; 4: 717–32
   Google Scholar
• Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H. Prevention of diabetes in non-obese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-α and interleukin 1. Proc Natl Acad Sci USA 1990; 87: 968–72
   PubMed Web of Science ®Google Scholar
• Dalbøge H, Bayne S, Christensen T, Hejnaes K. Cloning and expression of an interleukin-1β precursor and it conversion to interleukin-1β. FEBS Lett 1989; 246: 89–93
   PubMed Web of Science ®Google Scholar
• Mølvig J, Hansen BS, Worsaae H, Hejnaes KR, Helle M, Dalbøge H. Comparison of biological and immunological activities of human monocyte-derived interleukin 1β and human recombinant interleukin ip. Scand J Immunol 1990; 31: 225–35
   Google Scholar
• Bæk L. New, sensitive rocket Immunoelectrophoresis assay for measurement of the reaction between endotoxin and Limulus amoebocyte lysate. J Clin Microlbiol 1983; 17: 1013–20
   PubMed Web of Science ®Google Scholar
• Reimers J, Wogensen LD, Welinder B, Hejnaes KR, Poulsen SS, Nilsson P, Nerup J. The pharmacokinetics, distribution, and degradation of human recombinant interleukin 1β in normal rats. Scand J Immunol 1991; 34: 597–610
   PubMedGoogle Scholar
• Brunstedt J, Nielsen JH. Lernmark Å, Hagedom Study Group Isolation of islets from mice and rats. Methods in diabetes research laboratory methods. Vol I, J Lamer, SL Pohl. C. Wiley, New York 1984; 254–8
   Google Scholar
• Spinas GA, Hansen BS, Linde S, Kastern W, Mølvig J, Mandrup-Poulsen T, Dinarello CA, Nielsen JH, Nerup J. Interleukin-1 dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans. Diabetologia 1987; 30: 474–80
   PubMed Web of Science ®Google Scholar
• Greiner DL, Handler ES, Nakano K, Mordes JP, Rossini AA. Absence of the RT-6 T cell subset in diabetes-prone BB/W rats. J Immunol 1986; 136: 148–51
   PubMed Web of Science ®Google Scholar
• Zielasek J, Burkart V, Naylor P, Goldstein A, Kiesel U, Kolb H. Interleukin-2-dependent control of disease development in spontaneously diabetic BB rats. Immunology 1990; 69: 209–14
   PubMed Web of Science ®Google Scholar
• Kida K, Inoue T, Kaino Y, Goto Y, Ikeuchi M, Ito T, Matsuda H, Elliot RB. An immunopotentiator of β-1,6; 1,3 D-glucan prevents diabetes and insulitis in BB rats. Diab Res Clin Pract 1992; 17: 75–9
   Google Scholar
• Formby B, Jacobs C, Dubuc P, Shao T. Exogenous administration of IL-1α inhibits active and adoptive transfer autoimmune diabetes in NOD mice. Autoimmunity 1992; 12: 21–7
   PubMed Web of Science ®Google Scholar
• Seino H, Takahashi K, Zhu XP, Sagara M, Masuda T, Nobunaga T, Funahashi I, Kajikawa T, Toyota T. Prevention of autoimmune diabetes with lymphotoxin in NOD mice. Diabetes 1993; 42: 398–404
   Google Scholar
• Otterness IG, Seymour PA, Golden HW, Reynolds JA, Daumy GO. The effects of continuous administration of murine interleukin-la in the rat. Physiol Behav 1988; 43: 797–804
   Google Scholar
• Like AA, Guberski DL, Butler L. Diabetic BioBreeding/ Worcester (BB/Wor) rats need not to be lymphopenic. J Immunol 1986; 136: 3254–8
   PubMedGoogle Scholar
• Eastman S, Markholst H, Wilson D., Lernmark Å. Leukocytosis at the onset of diabetes in crosses of inbred BB rats. Diabetes Res Clin Pract 1991; 12: 113–23
   Google Scholar
• Crisà L, Sarkar P, Waite DJ, Haag F, Koch-Nolte F, Rajan TV, Mordes JP, Handler ES, Thiele H-G, Rossini AA, Greiner DL. An RT6a gene is transscribed and translated in lymphopenic diabetes-prone BB rats. Diabetes 1993; 42: 688–95
   Google Scholar
• Burstein D, Mordes JP, Greiner DL, Stein D, Nakamura N, Handler ES, Rossini AA. Prevention of diabetes in BB/Wor rats by single transfusion of spleen cells. Diabetes 1989; 38: 24–30
   PubMed Web of Science ®Google Scholar
• Marliss EB, Métroz-Dayer M-D., Montambault M, Faucher M, Grose M. Effects of single and repeated blood withdrawals on circulating mononuclear cells in BB rats. Diabetes 1990; 39: 1099–105
   Google Scholar
• Guberski DL., Thomson VA., Shek WR, Like AA, Handler ES, Rossini AA, Wallace JE, Welsh RM. Induction of type 1 diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science 1991; 254: 1010–3
   PubMed Web of Science ®Google Scholar
• Angelillo M, Greiner DL, Mordes JP, Handler ES, Nakamura N, McKeever U, Rossini A. Absence of RT6 + T-cells in diabetes-prone Biobreeding/Worcester rats due to genetic and cell developmental defects. J. Immunol 1988; 141: 4146–51
   PubMedGoogle Scholar
• Baekkeskov S, Dyrberg T., Lernmark Å. Autoantibodies to a 64-kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Sicence 1984; 224: 1348–50
   PubMed Web of Science ®Google Scholar
• Dyrberg T, Nakhooda AF, Baekkeskov S, Lernmark Å, Poussier P, Marliss EB. Islet cell surfase antibodies and lymphocyte antibodies in the spontaneously diabetic BB Wistar rat. Diabetes 1982; 31: 278–81
   PubMed Web of Science ®Google Scholar
• Like AA, Appel MC, Rossini AA. Autoantibodies in the BB/W rat. Diabetes 1982; 31: 816–20
   PubMed Web of Science ®Google Scholar
• Elder M, MacLaren N, Riley W, McConnell T. Gastric parietal cell and other autoantibodies in the BB rat. Diabetes 1982; 31: 313–8
   PubMed Web of Science ®Google Scholar
• Oldstone MBA, Tishon A, Schwimmbeck PL, Shyp S, Lewicki H, Dyrberg T. Cytotoxic T lymphocytes do not control lymphocytic choriomeningitis virus infection of BB diabetes-prone rats. J. Gen Virol 1990; 71: 785–91
   Google Scholar
• Contreas G, Dyrberg T, Madsen OD, Markholst H., Lernmark Å. Increased levels of cirkulating immune complexes are not associated with diabetes in BB rats. Diabetes Res 1989; 10: 109–13
   Google Scholar
• Galley P, Mach J-P, Carrel S. Characterization and detection of naturally occurring antibodies against IL-1α and IL-1β in normal human plasma. Eur Cytokine Netw 1991; 2: 329–38
   Google Scholar